MUSC Health’s Post

Join us in spreading awareness about World Digestive Health Day 🌐 Digestive health play a vital role in overall wellness. At Owlstone Medical, we recognize the impact that gastrointestinal disorders can have on individuals and communities worldwide. 🦠 The gut microbiome has been found to play a key role in diseases outside the gastrointestinal tract, such as cancer and metabolic-associated fatty liver disease (MAFLD). This highlights that improving digestive health will not only reduce the risk of developing gastrointestinal disorders, but also other diseases too. We are the leaders in the field of breath analysis for the early detection of many different diseases, including gastrointestinal disorders. We are dedicated to advancing innovative solutions for early and non-invasive disease diagnosis 👨⚕️ Breath biomarkers can provide unique insights into digestive conditions, revolutionizing the way we approach healthcare. #WDHD2024 #YourDigestiveHealth

Digestive diseases are a significant and growing health burden worldwide. Better methods of prevention and treatment are urgently needed. At UH Digestive Health Institute, clinicians and investigators are leading the way in this disease field with scientific research and clinical trials aimed at improving patient outcomes. UH, for example, is an integral member of the Cleveland Digestive Diseases Research Core Center, established in July 2015 with a 10-year grant from the National Institutes of Health (NIH). At the same time, UH and colleagues are embarked on a new five-year, $11.2 million NIH study of how Barrett’s esophagus, a precursor to esophageal cancer, develops — with an eye toward formulating new treatments. Other research efforts include studying the effect of artificial sweeteners on patients with inflammatory bowel disease (IBD) – a condition that affects more than 3 million Americans, as well as which dietary interventions may have an effect. Teams at UH are also using “big data” to look at the possible link between medications in patients with IBD and other conditions, including patients affected by COVID-19. Read more at https://lnkd.in/gxSGcER3 #digestivedisease #digestivehealth #IBD #clinicaltrials #patientsfirst

Embark on a journey to better gut health! Discover a wealth of insights in 'Gut Health: A Comprehensive Guide to Understanding and Managing Gastrointestinal Issues.' Explore expert tips, tricks, and must-knows for a happy gut. Ready to boost your digestive wellness? Dive in now! To shed light on this vital topic, an exclusive interview was done with Dr. Shivani Sharma, VP Pathology Services and Lab Director at CORE Diagnostics. Link - https://lnkd.in/g4ZH_zgd

In a time where managing gut health is being studied and pursued with more diligence than ever, the medical community is constantly finding new links between poor microbiotic balance and a wide range of diseases and disorders in the body. Learn about the many avenues our CDI researchers are taking to meet this revolution-by-revelation in medicine head-on. https://lnkd.in/eiGygv9X

🚨 The global conversation on liver health is gaining momentum, but there's so much more to be done! This recent piece from The New York Times (https://lnkd.in/gvxJdggi) is a breakthrough in raising awareness of metabolic dysfunction-associated steatotic liver disease (MASLD), formerly called NAFLD. It follows on the recent United Nations General Assembly  #UNGA2024 MASLD/MASH policy side-event, which also aimed to build visibility around the issue and promote the country-specific policy briefs ✍ published by the Economist Impact (https://lnkd.in/dXEAxMdk) Thank you The New York Times for featuring some of the key leaders in the field, including the #NYCMASH Cities co-chair Meena Bansal and Maru/Mary Rinella, who is participating in the #MASHCities 4-city awareness study on MASLD/MASH among the general population, people living with #diabetes and primary care professionals. We note that while New York City has a great #HealthyNYC plan to improve health outcomes, MASLD and MASH are not mentioned at all. 🙋♂️ 🙋♀️ We ask the NYC Department of Health and Mental Hygiene of Health and Mental Hygiene to fix this. All of these actions, from newspaper articles, to citywide and national action plans and strategies will prove vital as we push forward to end the MASLD/MASH #publichealth threat by raising awareness, driving policy changes, and improving health outcomes ↗️ Jeffrey V. Lazarus Nina Agrawal Icahn School of Medicine at Mount Sinai Joxel Garcia, MD, MBA NYC Health + Hospitals Fund for Public Health in NYC UChicago Medicine Fatty Liver Alliance Empire Liver Foundation (ELF) American Liver Foundation American Association for the Study of Liver Diseases (AASLD) Arun Sanyal Bloomberg Philanthropies Arizona Liver Health Rohit Kohli, MBBS, MS Tony Villiotti NASH kNOWledge Tom Frieden James McDonald MD MPH Scott Isaacs, MD, FACP, FACE Scott C. Ratzan MD Pam B. Dr. Ashwin Vasan Shyam Bishen, Ph.D., MS, MBA Vanessa Kerry, MD MSc Jay Bhatt Anthony Armenta Andrew Sollinger Naveen Rao Lars Hartenstein Kate Midden

We will be at the American Diabetes Association conference Friday evening and share back the insights from Kenneth Cusi and Karen Corbin, PhD, RD. Karen’s presentation will share her experience about “the impact of liver disease in people with type 2 diabetes. My presentation will highlight key nutritional concepts for improving metabolic targets and outcomes. These concepts will be preceded by a brief thought experiment about eliminating the “diet wars” that fuel confusion and misinformation.” Ken’s presentation “will summarize the year-long work in terms of liver health in diabetes by the ADA NAFLD Consensus group. The focus is on metabolic-dysfunction associated steatotic liver disease or MASLD (formerly NAFLD) and the new ADA management recommendations to manage this disease that is reaching epidemic proportions.” Zobair Younossi will be presenting Epidemiology/Hepatology of MASLD/MASH. mandeep bajaj will be discussing the new “Nomenclature, and Team-Based Care” in MASLD/MASH. American Association for the Study of Liver Diseases (AASLD), EASL | The Home of Hepatology, Canadian Association for the Study of the Liver, European Liver Patients' Association - ELPA, Barcelona Institute for Global Health (ISGlobal), Scott Isaacs, MD, FACP, FACE, Global NASH Council, The Forum for Collaborative Research: Liver Forum, Global Liver Institute

🌟✨ Reflecting on the first day of the World Congress of Inflammation from the IAIS in Québec ! ✨🌟 Organized by the International Association of Inflammation Societies (IAIS), under the leadership of Dr. Jason McDougall, President, and the Local Organizing Committee chaired by Dr. Marc Pouliot, Université Laval, the congress promises to be a resounding success ! The day kicked off with an extraordinary keynote lecture by Pr. Paul Kubes from the University of Calgary, titled "Homeostasis: Just a level of inflammation." Pr. Kubes introduced us to the concept of immunophysiology, explaining how the immune system integrates with tissues to maintain homeostasis and how its disruption leads to inflammation. His insights into the roles of alveolar macrophages in the lungs and Kupffer cells in the liver were truly enlightening. 🌟✨ Highlights from the WCI Symposium on Lung Inflammation ! ✨🌟 Following the inspiring keynote lecture by Pr. Paul Kubes, the "Novel Points of Control of Lung Inflammation" symposium, sponsored by GREMI, the French Society of Inflammation, and Ambiotis, delved into groundbreaking advancements in lung inflammation research. Chaired by Dr. Véronique Witko-Sarsat and Dr. Mustapha Si-Tahar, the session featured: 🔬 Effect of CFTR modulators on lung inflammation and neutrophil functions in cystic fibrosis by Dr. Véronique Witko-Sarsat 🔬 Neonatal cross-talk of alveolar macrophages and neutrophils regulating lung inflammation by Dr. Erwan Pernet 🔬 Metabolic control of virus-induced lung inflammation by Mustapha Si-Tahar 🔬 Specialized pro-resolving mediators in respiratory diseases by Prof. Bruce Levy Each speaker brought forth innovative insights and unveiled promising pathways for therapeutic breakthroughs, leaving us inspired and hopeful for the future of respiratory health. A heartfelt thank you to all the speakers and participants for making this session an incredible success! 🎉 #WCI #GREMI #LungInflammation #RespiratoryHealth #neutrophil #macrophage #cysticfibrosis #INSERM #InstitutCochin #CFTR #VirusInflammation #TherapeuticBreakthroughs

Research - Yale Medicine: Long COVID, ME/CFS and the Importance of Studying Infection-Associated Illnesses Research on Long COVID may also shine light on the underlying causes of myalgic encephalomyelitis/chronic fatigue syndrome, or ME/CFS. "Nothing new in this fairly comprehensive US review of the clinical and pathological overlaps between Long Covid and ME/CFS However, it's good to see that these medics from Yale are acknowledging that these overlaps exist and that a significant proportion of people with Long Covid meet diagnostic criteria for ME/CFS" Dr C Shepherd, Hon. Medical Adviser for the ME Association https://lnkd.in/egsYfGiv #MECFS #MyalgicEncephalomyelitis #diagnostics #Research

Our first MedTalk of the year is coming up on Tuesday, February 27! Join OANP and Dr. Penny Kendall-Reed for a live virtual lecture presentation on "The Impact of Inflammation on Health and Disease; Genetic Risks and Naturopathic Treatment" with Q&A. Abstract: The prevalence of diseases associated with chronic inflammation is anticipated to increase substantially over the next 30 years. The World Health Organization ranks chronic disease associated with inflammation as the greatest threat to human health. While up to 90% of human disease is related to activation of the stress system, evidence suggests that excessive inflammation plays a critical role in the pathophysiology of stress-related disease. In this lecture you will learn the direct and damaging impact inflammation has on various health issues such as cardiovascular disease, immunity and neural health. You will see why including inflammatory treatment in your therapeutic protocols is essential for the recovery and optimal health of your patients and the avoidance of cyclical and chronic disease. You will discover the key genes behind sources of inflammation and which individuals are more genetically susceptible. You will also learn how to treat these genes and conditions using lifestyle modification, diet and natural supplementation. Information will be illustrated using comparative case studies. Don't miss this one for 2 General CE starting at 6-8:30pm. Virtual and FREE for OANP Members. $40 for non-members. All are welcome to join! Learn more and register today at https://buff.ly/3swgmHW #naturopathicmedicine #naturopathicdoctor

October is Liver Awareness Month! At Diazyme Laboratories, we're dedicated to advancing liver health with innovative diagnostics. The liver plays a vital role in detoxifying our bodies, and early detection of liver dysfunction is key to preventing long-term damage. This month, we’re proud to highlight our comprehensive liver function markers: 🧬 Total Bile Acids (TBA) – Critical for assessing liver function and bile flow. 🧬 5'-Nucleotidase (5'NT) – Helps pinpoint liver disorders and differentiate them from bone diseases. 🧬 Adenosine Deaminase (ADA) – An essential marker for detecting liver disease and inflammation. Diazyme’s high-quality assays provide reliable results for accurate diagnosis and monitoring of liver conditions. Let’s work together to raise awareness, improve early detection, and support liver health! Learn More Here: https://bit.ly/3N2sBms #LiverAwarenessMonth #LiverHealth #Diagnostics #ADA #5NT #TBA #Diazyme #InnovationInHealth